Rodent Skin Model
Rodent Skin Model - Related Videos
09:40
Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
0 Views •
Cited by 35 •
2016
Pulmonary arterial hypertension (PAH) is a disease of pulmonary arterioles that leads to their obliteration and the development of right ventricular failure. Rodent models of PAH are critical in understanding the pathophysiology of PAH. Here we demonstrate hemodynamic characterization, with right heart catheterization and echocardiography, in the mouse and rat.
10:29
Principles of Rodent Surgery for the New Surgeon
0 Views •
Cited by 56 •
2011
Before attempting surgery, a new surgeon should have training in basic surgical techniques and concepts. This article will present basic surgical considerations with an emphasis on rodents.
03:02
Chemical-induced Two-stage Skin Carcinogenesis Model: An Experimental In Vivo Mouse Model of Skin Cancer
0 Views •
2023
This video describes the procedure to induce two-stage skin carcinogenesis to study tumor initiation by topical application of chemicals. In the first step, a mutagen, DMBA, is applied onto the skin of a mouse model which initiates tumor formation by causing mutations in the stem cells, followed by the application of a growth stimulator, TPA, which accelerates skin papilloma formation.
07:58
Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents
0 Views •
Cited by 14 •
2011
Partially isolated cortex (“undercut”) is an efficient animal model of posttraumatic epileptogenesis. Here we demonstrate how to make a novel surgical device and use it to make more precise and consistent lesions to generate this model.
04:07
Generation of Organotypic Full Skin Reconstructs: A Procedure to Establish 3D Skin Model Using Human Skin Samples
0 Views •
2023
This video describes the detailed protocol for generating in vitro 3D organotypic skin reconstructs to study melanoma progression. This skin model mimics both the architecture and multicellular complexity of organs in vivo.
FAQs
The most informative responses often span several levels of tissue behavior rather than a single visible sign. Changes in the epidermal barrier can be considered alongside immune signaling, cell proliferation, and tissue repair. Examining these responses together helps researchers determine whether a condition or treatment affects surface function, inflammatory activity, cellular growth, or recovery of damaged skin.
Each assessment provides a different layer of evidence. Clinical observations capture visible skin outcomes, histology examines tissue structure, and molecular assays identify underlying biological signals. Drug-response measurements add a treatment-focused comparison. Combining these approaches allows researchers to connect what happens externally with changes inside the tissue, producing a more informative interpretation than any single measurement alone.
Mouse and rat skin provide controlled biological contexts, but their responses may not correspond exactly to human skin responses. Differences between species therefore limit direct translation of experimental findings into clinical care. Researchers must interpret results within the model's biological context and treat evidence from a Rodent Skin Model as informative for medicine without assuming that every observed effect will occur in humans.
A typical workflow begins by selecting mouse or rat skin and defining the condition to be studied, such as a wound, infection, inflammation, or topical exposure. Researchers then monitor the resulting skin changes and assess them through clinical observations, histology, molecular assays, or drug-response measurements. This sequence links the introduced condition with structural, biological, and treatment-related outcomes.
Medical researchers can apply rodent skin models to questions involving wound healing, dermatologic disease, toxicology, and therapeutic development. The experimental condition is chosen to match the research question, while the readouts reveal how skin structure, immune signaling, proliferation, repair, or treatment response changes. This makes the approach useful for examining both disease-related processes and candidate interventions in a controlled setting.
Treatment studies can compare visible skin changes with tissue-level and molecular responses, while drug-response measurements indicate how the tested intervention performs under the defined experimental condition. The resulting data may show whether a treatment is associated with altered barrier function, immune signaling, cell proliferation, or repair. Such findings support therapeutic development, but require cautious interpretation before application to human care.